Showing 1 - 3 results of 3 for search 'Sorin Armeanu-Ebinger', query time: 0.01s Refine Results
  1. 1
    Attenuated and protease-profile modified sendai virus vectors as a new tool for virotherapy of solid tumors.

    Attenuated and protease-profile modified sendai virus vectors as a new tool for virotherapy of solid tumors. by Martina Zimmermann, Sorin Armeanu-Ebinger, Sascha Bossow, Johanna Lampe, Irina Smirnow, Andrea Schenk, Sebastian Lange, Thomas S Weiss, Wolfgang Neubert, Ulrich M Lauer, Michael Bitzer

    Published 2014-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Case Report: FGFR2 inhibitor resistance via PIK3CA and CDKN2A/B in an intrahepatic cholangiocarcinoma patient with FGFR2-SH3GLB1 fusion

    Case Report: FGFR2 inhibitor resistance via PIK3CA and CDKN2A/B in an intrahepatic cholangiocarcinoma patient with FGFR2-SH3GLB1 fusion by Nadja Ballin, Alexander Ott, Olga Seibel-Kelemen, Irina Bonzheim, Dominik Nann, Janina Beha, Stephan Spahn, Stephan Singer, Stephan Ossowski, Cristiana Roggia, Christopher Schroeder, Michael Bitzer, Michael Bitzer, Sorin Armeanu-Ebinger

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Adjuvant anti-PD-1 therapy improves melanoma-specific survival in stage IIIC-IV melanoma patients with high tumor mutation burden and BRAF V600 mutation

    Adjuvant anti-PD-1 therapy improves melanoma-specific survival in stage IIIC-IV melanoma patients with high tumor mutation burden and BRAF V600 mutation by Julia Forschner, Julia Huynh, Christopher Schroeder, Sorin Armeanu-Ebinger, Olga Seibel-Kelemen, Axel Gschwind, Irina Bonzheim, Thomas K. Eigentler, Teresa Amaral, Stephan Ossowski, Lukas Flatz, Claus Garbe, Andrea Forschner, Markus Reitmajer

    Published 2025-08-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: